Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling

4.5 (549) · $ 20.00 · In stock

Deciphering the gene regulatory circuitry governing chemoresistance in Triple-Negative Breast Cancer

Cancers, Free Full-Text

Cancers, Free Full-Text

IJMS, Free Full-Text

Frontiers ANLN Enhances Triple-Negative Breast Cancer Stemness Through TWIST1 and BMP2 and Promotes its Spheroid Growth

Nanomaterial-assisted CRISPR gene-engineering – A hallmark for triple-negative breast cancer therapeutics advancement - ScienceDirect

Cells, Free Full-Text

Super-enhancers switch on breast cancer genes

Frontiers ANLN Enhances Triple-Negative Breast Cancer Stemness Through TWIST1 and BMP2 and Promotes its Spheroid Growth

Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers

IJMS, Free Full-Text

IJMS, Free Full-Text

You may also like